Clinical Impact and Risk Factors of Intensive Care Unit-Acquired Nosocomial Infection: A Propensity Score-Matching Study from 2018 to 2020 in a Teaching Hospital in China.

Yanhui Wang, Jian Ren, Zhiqing Yao, Wei Wang, Siyang Wang, Junfang Duan, Zhen Li, Huizi Zhang, Ruiqin Zhang, Xiaoru Wang
Author Information
  1. Yanhui Wang: College of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  2. Jian Ren: Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  3. Zhiqing Yao: College of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  4. Wei Wang: Intensive Care Unit, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  5. Siyang Wang: Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  6. Junfang Duan: Intensive Care Unit, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  7. Zhen Li: College of Pharmacy, Chonnam National University, Gwangju, Korea.
  8. Huizi Zhang: College of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China. ORCID
  9. Ruiqin Zhang: Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  10. Xiaoru Wang: Intensive Care Unit, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.

Abstract

Purpose: Nosocomial Infection (NI) is associated with poor prognosis. The present study assessed the clinical and microbiological characteristics of NI patients in the intensive care unit (ICU) and investigated the clinical impact and risk factors for NI in ICU patients.
patients and Methods: An observational study was conducted in an adult general ICU. The electronic medical records of all patients admitted to the ICU for >2 days from 2018-2020 were analyzed retrospectively. Multivariate regression models were used to analyze the risk factors for NI in ICU patients. Propensity score-matching (PSM) was used to control the confounding factors between the case and control groups, thus analyzing the clinical impact of NIs.
Results: The present study included 2425 patient admissions, of which 231 (9.53%) had NI. (33.0%) was the most common bacteria. Long-term immunosuppressive therapy, disturbance of consciousness, blood transfusion, multiple organ dysfunction syndromes (MODS), treatment with three or more antibiotics, mechanical ventilation (MV), tracheotomy, the urinary catheter (UC), nasogastric catheter, and central venous catheter (CVC) were risk factors for NI in the ICU patients. After PSM, patients with NI had a prolonged length of stay (LOS) in the ICU and hospital, significant hospitalization expenses (all p<0.001), increased mortality (p=0.027), and predicted mortality (p=0.007). The differences in the ICU and hospital LOSs among three pathogens were statistically significant (p<0.001); the results of the infection group were lower than the other two pathogenic groups.
Conclusion: NI was associated with poor outcomes. The risk factors for NI identified in this study provided further insight into preventing NI.

Keywords

References

  1. Infect Control Hosp Epidemiol. 2010 Oct;31(10):1049-56 [PMID: 20731595]
  2. J Hosp Infect. 2018 May;99(1):36-41 [PMID: 29051092]
  3. Surgery. 2017 May;161(5):1376-1386 [PMID: 28024858]
  4. J Infect Public Health. 2019 Jul - Aug;12(4):568-575 [PMID: 30824329]
  5. Crit Care. 2019 Feb 18;23(1):52 [PMID: 30777109]
  6. Surg Infect (Larchmt). 2019 Jan;20(1):25-30 [PMID: 30234461]
  7. Rev Bras Ter Intensiva. 2012 Dec;24(4):357-61 [PMID: 23917933]
  8. Am J Infect Control. 2013 Jul;41(7):e59-63 [PMID: 23523521]
  9. PLoS One. 2019 Dec 23;14(12):e0225607 [PMID: 31869341]
  10. JAMA. 2014 Apr 2;311(13):1317-26 [PMID: 24691607]
  11. Asian Pac J Cancer Prev. 2014;15(13):5349-53 [PMID: 25041000]
  12. J Med Econ. 2017 Jan;20(1):28-36 [PMID: 27564685]
  13. Shock. 2017 Apr;47(4):429-435 [PMID: 27798537]
  14. Neurocrit Care. 2020 Oct;33(2):376-388 [PMID: 32705419]
  15. Int J Environ Res Public Health. 2021 Feb 24;18(5): [PMID: 33668288]
  16. Microb Drug Resist. 2018 Mar;24(2):190-198 [PMID: 28749714]
  17. Surg Clin North Am. 2012 Feb;92(1):65-77 [PMID: 22269261]
  18. J Orthop Res. 2021 Feb;39(2):227-239 [PMID: 31997412]
  19. Crit Care. 2017 Jan 6;21(1):2 [PMID: 28057057]
  20. J Infect. 2006 Aug;53(2):98-105 [PMID: 16343637]
  21. Zdr Varst. 2016 Jul 28;55(4):239-247 [PMID: 27703546]
  22. Am J Infect Control. 2015 Dec 1;43(12):e83-5 [PMID: 26315060]
  23. World J Crit Care Med. 2017 Feb 4;6(1):79-84 [PMID: 28224111]
  24. Antimicrob Resist Infect Control. 2018 Jan 5;7:2 [PMID: 29312659]
  25. Front Med (Lausanne). 2015 Apr 24;2:24 [PMID: 25964951]
  26. Rev Bras Enferm. 2021 Mar 24;74(1):e20200275 [PMID: 33787794]
  27. Infect Control Hosp Epidemiol. 2009 Jan;30(1):39-46 [PMID: 19046058]
  28. PLoS One. 2020 Jan 24;15(1):e0227772 [PMID: 31978169]
  29. Shock. 2021 Mar 1;55(3):326-331 [PMID: 32694393]
  30. PLoS One. 2014 Jan 21;9(1):e85973 [PMID: 24465819]
  31. Medicine (Baltimore). 2021 May 28;100(21):e26158 [PMID: 34032774]
  32. BMC Neurol. 2016 Aug 17;16(1):140 [PMID: 27535026]
  33. Crit Care Med. 2002 Oct;30(10):2249-54 [PMID: 12394952]
  34. Am J Infect Control. 2020 Oct;48(10):1211-1215 [PMID: 32093978]
  35. J Infect Chemother. 2015 Aug;21(8):570-4 [PMID: 26026660]
  36. BMC Health Serv Res. 2012 May 23;12:122 [PMID: 22621745]
  37. J Hosp Infect. 2011 May;78(1):36-40 [PMID: 21269733]
  38. Infect Control Hosp Epidemiol. 2007 Jun;28(6):713-9 [PMID: 17520546]
  39. Am J Infect Control. 2021 Feb;49(2):194-197 [PMID: 32621860]
  40. BMC Infect Dis. 2010 Jul 07;10:196 [PMID: 20609238]
  41. Surg Infect (Larchmt). 2006;7 Suppl 1:S19-22 [PMID: 16834543]
  42. JAMA. 2020 Apr 21;323(15):1478-1487 [PMID: 32207816]

Word Cloud

Created with Highcharts 10.0.0NIICUpatientsstudyfactorsriskinfectionclinicalcatheterNosocomialassociatedpoorpresentintensivecareunitimpactusedPropensityscore-matchingPSMcontrolgroupsthreehospitalsignificantp<0001mortalityp=0ChinaPurpose:prognosisassessedmicrobiologicalcharacteristicsinvestigatedPatientsMethods:observationalconductedadultgeneralelectronicmedicalrecordsadmitted>2days2018-2020analyzedretrospectivelyMultivariateregressionmodelsanalyzeconfoundingcasethusanalyzingNIsResults:included2425patientadmissions231953%330%commonbacteriaLong-termimmunosuppressivetherapydisturbanceconsciousnessbloodtransfusionmultipleorgandysfunctionsyndromesMODStreatmentantibioticsmechanicalventilationMVtracheotomyurinaryUCnasogastriccentralvenousCVCprolongedlengthstayLOShospitalizationexpensesincreased027predicted007differencesLOSsamongpathogensstatisticallyresultsgrouplowertwopathogenicConclusion:outcomesidentifiedprovidedinsightpreventingClinicalImpactRiskFactorsIntensiveCareUnit-AcquiredInfection:Score-MatchingStudy20182020TeachingHospitalNorthepidemiologynosocomialpropensityretrospective

Similar Articles

Cited By (6)